Literature DB >> 12374063

Medicare to partly cover extra cost of sepsis therapy, drug-eluting stents.

Cheryl A Thompson.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12374063     DOI： 10.1093/ajhp/59.19.1816

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  2 in total

1.  An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre.

Authors:  Michael A Fischer; Craig M Lilly; William W Churchill; Lindsey R Baden; Jerry Avorn
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 2.  Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsis.

Authors:  James E Frampton; Rachel H Foster
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.